Humana Inc. (HUM) Price CAGR:55.87%(TTM)
The price cagr for Humana Inc. (HUM) is +55.87% over the latest trailing 12-month period. The comparable SPY value is +22.92%. Year-to-date price return is +37.32%. Price CAGR uses adjusted close price history and excludes dividends.
The price cagr for Humana Inc. (HUM) stock is 55.87% over the past 12 months. The 3 year average growth rate is -10.89% and the 5 year cagr is -2.99%. The price CAGR (Compound Annual Growth Rate) shows how Humana Inc.'s stock price has grown over various time periods. This measures pure price appreciation without including dividends.
HUM Price CAGR Chart
Humana Inc. (HUM)
HUM Price CAGR History
| Year | Start Price | End Price | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | 358.04 | 239.90 | -118.14 | -33.00% | -33.00% |
| 2024 | 456.44 | 358.04 | -98.40 | -21.56% | -21.56% |
| 2023 | 448.98 | 456.44 | +7.46 | +1.66% | +1.66% |
| 2022 | 435.55 | 448.98 | +13.43 | +3.08% | +3.08% |
| 2021 | 380.76 | 435.55 | +54.79 | +14.39% | +14.39% |
| 2020 | 258.83 | 380.76 | +121.93 | +47.11% | +47.11% |
| 2019 | 299.81 | 258.83 | -40.98 | -13.67% | -13.67% |
| 2018 | 235.49 | 299.81 | +64.32 | +27.31% | +27.31% |
| 2017 | 187.15 | 235.49 | +48.34 | +25.83% | +25.83% |
| 2016 | 199.30 | 187.15 | -12.15 | -6.10% | -6.10% |
| 2015 | 124.86 | 199.30 | +74.44 | +59.62% | +59.62% |
| 2014 | 83.60 | 124.86 | +41.26 | +49.35% | +49.35% |
| 2013 | 79.02 | 83.60 | +4.58 | +5.80% | +5.80% |
| 2012 | 78.27 | 79.02 | +0.75 | +0.96% | +0.96% |
| 2011 | 48.83 | 78.27 | +29.44 | +60.29% | +60.29% |
| 2010 | 28.28 | 48.83 | +20.55 | +72.67% | +72.67% |
| 2009 | 46.41 | 28.28 | -18.13 | -39.06% | -39.06% |
| 2008 | 60.19 | 46.41 | -13.78 | -22.89% | -22.89% |
| 2007 | 49.41 | 60.19 | +10.78 | +21.82% | +21.82% |
| 2006 | 39.48 | 49.41 | +9.93 | +25.15% | +25.15% |
| 2005 | 16.01 | 39.48 | +23.47 | +146.60% | +146.60% |
| 2004 | 15.20 | 16.01 | +0.81 | +5.33% | +5.33% |
| 2003 | 16.51 | 15.20 | -1.31 | -7.93% | -7.93% |
| 2002 | 10.20 | 16.51 | +6.31 | +61.86% | +61.86% |
| 2001 | 5.19 | 10.20 | +5.01 | +96.53% | +96.53% |
| 2000 | 14.63 | 5.19 | -9.44 | -64.52% | -64.52% |
| 1999 | 30.50 | 14.63 | -15.87 | -52.03% | -52.03% |
| 1998 | 23.88 | 30.50 | +6.62 | +27.72% | +27.72% |
| 1997 | 18.00 | 23.88 | +5.88 | +32.67% | +32.67% |
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin